Federica Tomao | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer	VIRCHOWS ARCHIV	2020
The role of 2d/3d ultrasound to assess the response to neoadjuvant chemotherapy in locally advanced cervical cancer	ONCOLOGY	2020
Recurrent mantle cell lymphoma in the uterine cervix: a case report	JOURNAL OF MEDICAL CASE REPORTS	2020
First-line treatment with olaparib for early stage BRCA-positive ovarian cancer: May it be possible? Hypothesis potentially generating a line of research	CANCER MANAGEMENT AND RESEARCH	2020
ESMO management and treatment adapted recommendations in the COVID-19 era: Gynaecological malignancies	ESMO OPEN	2020
Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer	GYNECOLOGIC ONCOLOGY	2020
Ovarian Cancer Metastasis to the Breast: A Case Report and Review of the Literature	CASE REPORTS IN ONCOLOGY	2020
Immunotherapy for ovarian cancer: recent advances and therapeutic combination approach	ONCOTARGETS AND THERAPY	2020
The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients	JOURNAL OF GYNECOLOGIC ONCOLOGY	2019
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?	GYNECOLOGIC ONCOLOGY	2019
Evaluation of CA125 and HE4 diagnostic performance in hereditary and sporadic ovarian cancer	CLINICA CHIMICA ACTA	2019
The EOLO (End-of-Life Ovarian Cancer) Study: Approach to ovarian cancer patients at the end of life	ONCOLOGY	2019
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting	INTERNATIONAL JOURNAL OF CANCER	2019
RE: Universal tumor DNA BRCA1/2 testing of ovarian cancer: prescreening PARPi treatment and genetic predisposition	JOURNAL OF THE NATIONAL CANCER INSTITUTE	2019
Paclitaxel and Alisertib in recurrent ovarian cancer	JAMA ONCOLOGY	2019
Adjuvant therapy for early uterine high-grade leiomyosarcoma	JOURNAL OF CLINICAL ONCOLOGY	2019
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer	JOURNAL OF CLINICAL MEDICINE	2019
Etirinotecan pegol in women with recurrent platinum-resistant or refractory ovarian cancer.	EXPERT OPINION ON INVESTIGATIONAL DRUGS	2019
Intraperitoneal Chemotherapy: A Strategy for the Treatment of Refractory Ascites in Recurrent Endometrial Cancer Patients - Three Case Reports and Review of the Literature	ONCOLOGY	2019
Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development	CANCER CHEMOTHERAPY AND PHARMACOLOGY	2019